Brief: Spyre Therapeutics Inc - SPY001 Well Tolerated With Favorable Safety Profile
12/11/2024 13:17
Nov 12 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* SPYRE THERAPEUTICS INC - SPY001 WELL TOLERATED WITH
FAVORABLE
SAFETY PROFILE
* SPYRE THERAPEUTICS INC - ANNOUNCES POSITIVE INTERIM
RESULTS FOR
SPY001
Source text: ID:nPn1lf1nHa
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock